יחס מחיר לרווח Creative Medical Technology Holdings (CELZ)

Creative Medical Technology (CELZ) operates in the high-risk tissue regeneration sector, where the primary threats remain a lack of profitability, potential failures in diabetes drug trials, and liquidity shortages. This price chart reflects the asset's dynamics, with its current value standing at -0.60. Creative Medical Technology (CELZ) protects its urological developments through patents while competing within the biomedicine niche. Additionally, the business is implementing eco-friendly reactors to comply with bio-waste disposal regulations.

The business stability of Creative Medical Technology (CELZ) is based on exclusive rights to stem cell therapy. This asset determines the net profit, which serves as the denominator in calculating the return on investment ratio. This metric compares market capitalization with actual earnings to measure the payback period of invested capital. An analysis of the company's normalized P/E allows for the separation of speculative noise from fundamental value. The normalized P/E trend reveals critical points of asset overvaluation or undervaluation.